Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine was initially stored in the refrigerator on 22-Aug-2022 and administered on 27-Sep-2022; No Adverse event; patient given vaccine after BUD date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 22-Aug-2022 and administered on 27-Sep-2022) and NO ADVERSE EVENT (No Adverse event) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR9236B and AR9237B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Hepb-ped on 24-Jan-2020, DTaP-IPV/Hib (LOT number: UJ288AAA, Route IM, Site RVL`) on 05-Mar-2020, PNEUMOCOCCAL CONJUGATE VACCINE (LOT number: CM0898 Route IM  site LVL) on 05-Mar-2020, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UJ258AAA, Route IM, Site RVL) on 05-Mar-2020, POLIO (LOT number:  UJ258AAA Route IM site RVL) on 05-Mar-2020, Hepb-ped (LOT number: P7284, Route IM, Site RVL) on 06-Mar-2020, ROTAVIRUS VACCINE (LOT number: L6G89 Route PO) on 06-Mar-2020, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UJ403AAA, Route IM, Site RVL) on 26-Apr-2020, POLIO (LOT number:  UJ214AAA Route IM site RVL) on 08-Jun-2020, ROTAVIRUS VACCINE (LOT number: L5G93 Route PO) on 09-Jun-2020, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UJ214AAA, Route IM, Site RVL) on 09-Jun-2020, PNEUMOCOCCAL CONJUGATE VACCINE (LOT number: CW5293 Route IM  site LVL) on 09-Jun-2020, DTaP-IPV/Hib (LOT number: UJ214AAA, Route IM, Site RVL`) on 08-Aug-2020, POLIO (LOT number:  UJ2614AAA Route IM site RVL) on 11-Aug-2020, Hepb-ped (LOT number: 9KG7R, Route IM, Site RVL) on 11-Aug-2020, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UJ261AAA,Route IM, Site RVL) on 11-Aug-2020, PNEUMOCOCCAL CONJUGATE VACCINE (LOT number: DF1208 Route IM  site LVL) on 11-Aug-2020, DTaP-IPV/Hib (LOT number: UJ281AAA, Route IM, Site RVL) on 11-Aug-2020, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UJ403AAA, Route IM, Site LD) on 12-Nov-2020, MMR (LOT number: 8088319 Route SC Site LVL) on 01-Feb-2021, VARICELLA VACCINE (LOT number: T002846  Route SC site LVL) on 01-Feb-2021, Hepa-Ped (LOT number: 823EA, Route IM, Site RVL) on 01-Feb-2021, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UT7108LA, Route IM, Site RVL) on 01-Feb-2021, PNEUMOCOCCAL CONJUGATE VACCINE (LOT number: DR0570 Route IM site LVL) on 26-Apr-2021, POLIO (LOT number:  UJ403AAA Route IM site RVL) on 28-Apr-2021, DTaP-IPV/Hib (LOT number: UJ403AAA, Route IM, Site RVL) on 28-Apr-2021, Hepa-Ped (LOT number: 7MJ74, Route IM, Site RVL) on 12-Aug-2021, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: 8XX32,  Route IM, Site LVL, Booster.) on 14-Aug-2021, HAEMOPHILUS INFLUENZAE TYPE B (LOT number: UT7682MA, Route IM, Site LT andBooster.) on 29-Aug-2022. Past adverse reactions to the above products included No adverse event with DTaP-IPV/Hib, DTaP-IPV/Hib, DTaP-IPV/Hib, DTaP-IPV/Hib, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, HAEMOPHILUS INFLUENZAE TYPE B, Hepa-Ped, Hepa-Ped, Hepb-ped, Hepb-ped, Hepb-ped, MMR, PNEUMOCOCCAL CONJUGATE VACCINE, PNEUMOCOCCAL CONJUGATE VACCINE, PNEUMOCOCCAL CONJUGATE VACCINE, PNEUMOCOCCAL CONJUGATE VACCINE, POLIO, POLIO, POLIO, POLIO, ROTAVIRUS VACCINE, ROTAVIRUS VACCINE and VARICELLA VACCINE.   On 23-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Sep-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 27-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 22-Aug-2022 and administered on 27-Sep-2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 22-Aug-2022 and administered on 27-Sep-2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 22-Aug-2022 and administered on 27-Sep-2022).    No concomitant medication was reported.  It was reported that vaccine coordinator was calling to report that some patients (Adults and Pediatrics) received expired Moderna COVID-19 vaccine after 30 day beyond use date (22-Sep-2022).  There were unbroken cartons. Vial size for 6 months to 5 year. The vial was initially stored in the refrigerator on 22-Aug-2022. The patient was given vaccine after BUD date.  The vial did not undergo any temperature excursions.  No treatment medication was reported.